Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Zero travel fees
BPC-157 detection has been the subject of specific research
In the limited human research conducted, DSIP was generally described as well tolerated, with few acute adverse events reported at the doses studied
PMCID: PMC6826538 Blackburn PR, Xu Z, Tumelty KE, Zhao RW, Monis WJ, Harris KG, Gass JM, Cousin MA, Boczek NJ, Mitkov MV, Cappel MA, Francomano CA, Parisi JE, Klee EW, Faqeih E, Alkuraya FS, Layne MD, McDonnell NB, Atwal PS
Without the DAC group, the peptide is short-acting it clears within a few hours and produces a sharp, brief GH pulse
Injectable BPC-157 Injectable research use is more commonly discussed for: Tendon recovery Ligament healing Muscle injuries Joint-related tissue recovery Wound repair Systemic tissue-protection research The theoretical advantage is more predictable systemic exposure compared with oral administration
